PubRank

Daniel T Laskowitz

Author PubWeight™ 88.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013 3.90
2 Central nervous system injury associated with cardiac surgery. Lancet 2006 2.27
3 Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery. Stroke 2013 2.05
4 Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit Care Med 2007 1.89
5 Novel diagnostic test for acute stroke. Stroke 2003 1.82
6 APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 2003 1.80
7 APOE polymorphism is associated with risk of severe sepsis in surgical patients. Crit Care Med 2005 1.70
8 Cognitive function after major noncardiac surgery, apolipoprotein E4 genotype, and biomarkers of brain injury. Anesthesiology 2010 1.68
9 Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med 2014 1.60
10 Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002 1.57
11 Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med 2006 1.51
12 Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 2005 1.44
13 Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol Res 2002 1.43
14 Challenges in enrollment of minority, pediatric, and geriatric patients in emergency and acute care clinical research. Ann Emerg Med 2008 1.42
15 Early biomarkers of stroke. Clin Chem 2003 1.41
16 A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp Neurol 2005 1.34
17 Preclinical models of intracerebral hemorrhage: a translational perspective. Neurocrit Care 2008 1.29
18 Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol 2007 1.26
19 Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. J Pharmacol Exp Ther 2006 1.14
20 A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care 2006 1.09
21 Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage. Stroke 2008 1.07
22 Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic Biol Med 2002 1.06
23 The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 2002 1.05
24 Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003 1.05
25 Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema. Ann Neurol 2002 1.05
26 Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. Stroke 2009 1.02
27 Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 2002 1.02
28 Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage. J Neuroinflammation 2013 1.01
29 S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage. Biomarkers 2009 1.00
30 Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 2004 1.00
31 Apolipoprotein E modifies neurological outcome by affecting cerebral edema but not hematoma size after intracerebral hemorrhage in humans. J Stroke Cerebrovasc Dis 2009 0.99
32 Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage. J Clin Neurosci 2012 0.99
33 Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus 2006 0.98
34 Depression and antidepressant use after stroke and transient ischemic attack. Stroke 2012 0.97
35 Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association. Circulation 2015 0.96
36 Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience. J Neurosurg 2006 0.95
37 Long-term cognitive dysfunction following experimental subarachnoid hemorrhage: new perspectives. Exp Neurol 2008 0.94
38 Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice. J Neurotrauma 2010 0.93
39 Predictors of late neurological deterioration after spontaneous intracerebral hemorrhage. Neurocrit Care 2013 0.93
40 Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocrit Care 2006 0.92
41 Apolipoprotein E expression and behavioral toxicity of high charge, high energy (HZE) particle radiation. J Radiat Res 2002 0.90
42 Evolving role of biomarkers in acute cerebrovascular disease. Ann Neurol 2012 0.90
43 Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic-ischemic injury. Neurosci Lett 2005 0.90
44 Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach. J Neurotrauma 2012 0.89
45 Statins in traumatic brain injury. Neurotherapeutics 2010 0.89
46 Real-time 3-D contrast-enhanced transcranial ultrasound and aberration correction. Ultrasound Med Biol 2008 0.88
47 Clinical application of blood biomarkers in cerebrovascular disease. Expert Rev Neurother 2010 0.87
48 A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 2010 0.86
49 Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity. J Biol Chem 2012 0.86
50 Gender and age interact to affect early outcome after intracerebral hemorrhage. PLoS One 2013 0.86
51 Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 2002 0.86
52 Apolipoprotein E protects against NMDA excitotoxicity. Neurobiol Dis 2002 0.85
53 TT-301 inhibits microglial activation and improves outcome after central nervous system injury in adult mice. Anesthesiology 2012 0.85
54 Apolipoprotein E4 increases aortic atheroma burden in cardiac surgical patients. J Thorac Cardiovasc Surg 2003 0.84
55 The ultrasound brain helmet: feasibility study of multiple simultaneous 3D scans of cerebral vasculature. Ultrasound Med Biol 2008 0.84
56 ApolipoproteinE mimetic peptides improve outcome after focal ischemia. Exp Neurol 2012 0.83
57 Effects of a manganese (III) porphyrin catalytic antioxidant in a mouse closed head injury model. Eur J Pharmacol 2006 0.83
58 The ultrasound brain helmet: new transducers and volume registration for in vivo simultaneous multi-transducer 3-D transcranial imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2011 0.83
59 Preoperative statin therapy does not reduce cognitive dysfunction after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2005 0.82
60 Interaction between sex and apolipoprotein e genetic background in a murine model of intracerebral hemorrhage. Transl Stroke Res 2012 0.82
61 Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway. Neurol Res 2007 0.81
62 Lacosamide improves outcome in a murine model of traumatic brain injury. Neurocrit Care 2013 0.80
63 pH-sensitive NMDA inhibitors improve outcome in a murine model of SAH. Neurocrit Care 2014 0.80
64 Simvastatin treatment duration and cognitive preservation in experimental subarachnoid hemorrhage. J Neurosurg Anesthesiol 2009 0.80
65 Differential cerebral gene expression during cardiopulmonary bypass in the rat: evidence for apoptosis? Anesth Analg 2002 0.79
66 Discriminative capacity of biomarkers for acute stroke in the emergency department. J Emerg Med 2010 0.79
67 Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. Stroke 2003 0.78
68 Simultaneous bilateral real-time 3-d transcranial ultrasound imaging at 1 MHz through poor acoustic windows. Ultrasound Med Biol 2013 0.78
69 Biomarkers in traumatic brain injury. Curr Neurol Neurosci Rep 2012 0.78
70 Teaching neuroimages: vein of Galen aneurysm mimicking pineal mass in a young adult. Neurology 2013 0.77
71 Galbraith Award: simvastatin attenuates experimental cerebral vasospasm and ameliorates serum markers of neuronal and endothelial injury in patients after subarachnoid hemorrhage: a dose-response effect dependent on endothelial nitric oxide synthase. Clin Neurosurg 2005 0.77
72 Neighborhood socioeconomic status and the prevalence of stroke and coronary heart disease in rural China: a population-based study. Int J Stroke 2014 0.77
73 A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhage. Oligonucleotides 2010 0.76
74 Management of post-subarachnoid hemorrhage vasospasm. Curr Atheroscler Rep 2008 0.76
75 Biomarkers in stroke: when will they impact care? J Am Coll Cardiol 2010 0.75
76 Letter by El Husseini et al regarding article, "What causes disability after transient ischemic attack and minor stroke?". Stroke 2012 0.75
77 3-D transcranial ultrasound imaging with bilateral phase aberration correction of multiple isoplanatic patches: a pilot human study with microbubble contrast enhancement. Ultrasound Med Biol 2013 0.75
78 Apolipoprotein epsilon 4 genotype is associated with less improvement in cognitive function five years after cardiac surgery: a retrospective cohort study. Can J Anaesth 2015 0.75
79 Statins in acute brain injury: getting the cart before the horse. Neurocrit Care 2008 0.75
80 Defining optimal cerebral perfusion pressures in acute brain injury: a step toward individualization of care? Crit Care Med 2010 0.75
81 The use of S100B as a biomarker in subarachnoid hemorrhage: clarity in its promise and limits. Crit Care Med 2008 0.75
82 Can D-dimer levels identify patients at risk for early neurological deterioration in acute ischemic stroke? Nat Clin Pract Neurol 2006 0.75
83 The role of neuroendocrine pathways in prognosis after stroke. Expert Rev Neurother 2014 0.75
84 Response to letter regarding article, "Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery". Stroke 2014 0.75
85 Changing outcome from aneurysmal subarachnoid hemorrhage: another step closer. Anesthesiology 2006 0.75
86 871 Simvastatin Reduces Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Results of a Pilot Randomized Clinical Trial. Neurosurgery 2005 0.75
87 Progressive multifocal leukoencephalopathy with occult Waldenström macroglobulinemia. J Clin Oncol 2010 0.75
88 Erratum: Neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral hemorrhage. Sci Rep 2017 0.75
89 Synthes Award for Resident Research in Spinal Cord & Spinal Column Injury: Statins for the treatment of neurological injury: a role beyond cholesterol lowering. Clin Neurosurg 2004 0.75
90 813 Intracerebral Infusion of Human Recombinant Apolipoprotein E3 Reduces Global Ischemic Brain Injury in Apolipoprotein E Deficient Mice. Neurosurgery 2000 0.75
91 813 Intracerebral Infusion of Human Recombinant Apolipoprotein E3 Reduces Global Ischemic Brain Injury in Apolipoprotein E Deficient Mice. Neurosurgery 2000 0.75
92 Use of emergency department transcranial Doppler assessment of reperfusion after intravenous tPA for ischemic stroke. J Emerg Med 2008 0.75